Literature DB >> 2023057

Correlation of Histoplasma capsulatum polysaccharide antigen with the severity of infection in murine histoplasmosis.

B J Williams1, P Connolly-Stringfield, M Bartlett, M Durkin, T Garringer, R Blair, K Connolly, R P Tewari, L J Wheat.   

Abstract

We sought to determine if Histoplasma capsulatum polysaccharide antigen (HPA) levels correlate with the extent of infection in murine of histoplasmosis. Separate groups of mice were inoculated intratracheally with varying numbers of H. capsulatum yeast cells. After 1 week, HPA levels and fungal burden (quantitative culture of lung and spleen and histopathologic stain of lung) were determined in lung and spleen, and HPA levels in serum. HPA levels, cultures and histopathological stain results of lung and spleen tissue showed a direct correlation with increasing inoculum size. HPA levels in serum also correlated with the size of inoculum. H. capsulatum antigen in lung correlated with silver stain scores of lung tissue, (R = 0.948, P less than 0.001) and with quantitative culture scores of lung, (R = 0.929, P less than 0.001). HPA levels in spleen tissue also correlated with spleen culture scores, (R = 0.724, P less than 0.001). These results indicate that determination of HPA level in serum and tissue may be a useful test in evaluating the severity of diseases as well as efficacy of antifungal therapy in histoplasmosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2023057     DOI: 10.1002/jcla.1860050209

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  2 in total

1.  Glycosylation and immunoreactivity of the Histoplasma capsulatum Cfp4 yeast-phase exoantigen.

Authors:  Eric D Holbrook; Megan M Kemski; Sarah M Richer; L Joseph Wheat; Chad A Rappleye
Journal:  Infect Immun       Date:  2014-08-11       Impact factor: 3.441

2.  Local immunity in lung-associated lymph nodes in a murine model of pulmonary histoplasmosis.

Authors:  M F Fojtasek; M R Sherman; T Garringer; R Blair; L J Wheat; C T Schnizlein-Bick
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.